Association of Central Serous Chorioretinopathy with single-nucleotide polymorphisms in Complement Factor H Gene in a Chinese population
暂无分享,去创建一个
Yuou Yao | Enzhong Jin | Mingwei Zhao | Lvzhen Huang | D. Linghu | J. Qu | Hui Xu | Tingting Gao | Yuepeng Cao
[1] M. Gazouli,et al. PREVALENCE OF THE COMPLEMENT FACTOR H AND GSTM1 GENES POLYMORPHISMS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY , 2016, Retina.
[2] A. D. den Hollander,et al. Genomic Copy Number Variations of the Complement Component C4B Gene Are Associated With Chronic Central Serous Chorioretinopathy. , 2015, Investigative ophthalmology & visual science.
[3] A. D. den Hollander,et al. Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration. , 2015, Ophthalmology.
[4] T. Yakut,et al. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels , 2014, Cutaneous and ocular toxicology.
[5] J. Slakter,et al. Cadherin 5 is Regulated by Corticosteroids and Associated with Central Serous Chorioretinopathy , 2014, Human mutation.
[6] A. Negi,et al. Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy. , 2014, Ophthalmology.
[7] Shicheng Guo,et al. Different hereditary contribution of the CFH gene between polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese Han people. , 2014, Investigative ophthalmology & visual science.
[8] K Bailey Freund,et al. PACHYCHOROID PIGMENT EPITHELIOPATHY , 2013, Retina.
[9] G. Liew,et al. Diagnosis and interventions for central serous chorioretinopathy: review and update , 2013, Clinical & experimental ophthalmology.
[10] Poemen P. Chan,et al. Risk Factors for Recurrence of Serous Macular Detachment in Untreated Patients with Central Serous Chorioretinopathy , 2011, Ophthalmic Research.
[11] A. Lotery,et al. Central serous chorioretinopathy: an update on pathogenesis and treatment , 2010, Eye.
[12] L. Yannuzzi. Central serous chorioretinopathy: a personal perspective. , 2010, American journal of ophthalmology.
[13] M. Eichelbaum,et al. Highly multiplexed genotyping of thiopurine s-methyltransferase variants using MALD-TOF mass spectrometry: reliable genotyping in different ethnic groups. , 2008, Clinical chemistry.
[14] A. Koh,et al. Angiographic characteristics of acute central serous chorioretinopathy in an Asian population. , 2006, Annals of the Academy of Medicine, Singapore.
[15] E. Bouzas,et al. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case–control study , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[16] M. Wolzt,et al. Effects of adrenomedullin on ocular hemodynamic parameters in the choroid and the ophthalmic artery. , 2003, Investigative ophthalmology & visual science.
[17] Kazuhiro Takahashi,et al. Adrenomedullin in the eye , 2003, Regulatory Peptides.
[18] L. Yannuzzi,et al. Corticosteroids and central serous chorioretinopathy. , 2002, Ophthalmology.
[19] J. Slakter,et al. Systemic findings associated with central serous chorioretinopathy. , 1999, American journal of ophthalmology.
[20] M. Wakakura,et al. Corticosteroid-induced central serous chorioretinopathy. , 1997, Japanese journal of ophthalmology.
[21] S. Carlesimo,et al. [Masuda's Central Serous Chorioretinopathy (C.S.C.R.) and its somatic investment in Narcissism: our observations on new psychiatric nosography]. , 2014, La Clinica terapeutica.
[22] L. Yannuzzi. TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHY , 2012, Retina.
[23] Frcs,et al. Central Serous Chorioretinopathy , 2012 .